| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/04/2004 | US20040043073 Mixture of wax and drug; sustained release |
| 03/04/2004 | US20040043072 Alleviation of upper gastrointestinal irritation |
| 03/04/2004 | US20040043069 Stable oral formulation containing benzimidazole derivative |
| 03/04/2004 | US20040043067 Fluorosiloxane matrix controlled diffusion drug delivery systems |
| 03/04/2004 | US20040043066 Levothyroxine compositions having unique triiodothyronine Tmax properties |
| 03/04/2004 | US20040043065 Controlled release formulations containing an active ingredient, preferably melatonin, and the method of preparation |
| 03/04/2004 | US20040043057 Mixture of ferulic acid, caffeine and chlorogenic acid |
| 03/04/2004 | US20040043056 Diet composition comprising raw foods and dietary fibers |
| 03/04/2004 | US20040043055 Method of reducing body weight and/or body fat with L-glutamine compounds |
| 03/04/2004 | US20040043054 Composition and method to augment and sustain neurotransmitter production |
| 03/04/2004 | US20040043026 Treatment and prevention of abnormal scar formation in keloids and other cutaneous or internal wounds or lesions |
| 03/04/2004 | US20040043022 Immunology diseases; rheumatic disorders; anticancer agents; antiinflammatory agents; multiple sclerosis; lymphocyte stimulants |
| 03/04/2004 | US20040043013 Metabolic uncoupling therapy |
| 03/04/2004 | US20040043011 Use of agents active against candida in the treatment of disorders of the oral and intestinal mucosa |
| 03/04/2004 | US20040043001 Pharmaceutical formulations of antineoplastic agents and processes of making and using the same |
| 03/04/2004 | US20040042993 Composition containing an active agent and a ligand-receptor system, and process |
| 03/04/2004 | US20040042990 Composition containing oxidation-sensitive hydrophilic active principle and maleic anhydride copolymer, and use thereof |
| 03/04/2004 | US20040042982 Topical applying alendronate sodium |
| 03/04/2004 | US20040042978 Mixture of stannous fluoride and zinc compound |
| 03/04/2004 | US20040042973 Anhydrous mometasome furoate mixture with surfactant and propellant; pressurized vessel; controlling particle size distribution |
| 03/04/2004 | US20040042971 Spray freeze dry of compositions for pulmonary administration |
| 03/04/2004 | US20040042970 Inhalable sustained therapeutic formulations |
| 03/04/2004 | US20040042964 Pharmaceutical composition which reduces or eliminates drug abuse potential |
| 03/04/2004 | US20040040227 Material for improving living environment, and building material, laying material and spraying agent using the same |
| 03/04/2004 | DE4325465B4 Orales pharmazeutisches Präparat für die Schmerztherapie An oral pharmaceutical composition for the treatment of pain |
| 03/04/2004 | DE10337458A1 Verbesserungen bei der Extraktion von pharmazeutisch aktiven Komponenten aus Pflanzenmaterialien Improvements in the extraction of pharmaceutically active components from plant materials |
| 03/04/2004 | DE10240923A1 Flavonoid-Derivate zur Ekzem-Behandlung Flavonoid derivatives for eczema treatment |
| 03/04/2004 | DE10239531A1 Prophylaxe und Therapie von Infektionserkrankungen Prophylaxis and therapy of infectious diseases |
| 03/04/2004 | DE10239042A1 New fused macrocyclic pyrimidine derivatives, useful as e.g. cyclin-dependent kinase inhibitors for treating e.g. cancer, autoimmune, cardiovascular or neurodegenerative diseases or viral infections |
| 03/04/2004 | DE10238298A1 Verwendung von Antisense-Oligonucleotiden zur Behandlung von degenerativen Hauterscheinungen Use of antisense oligonucleotides for treatment of degenerative phenomena of skin |
| 03/04/2004 | DE10238169A1 Verfahren zur vereinfachten Herstellung einer Zusammensetzung mit hohem Avarolgehalt mit verbesserter Wirkung sowie dessen Verwendung zur Behandlung proliferativer Funktionsstörungen oder zur Herstellung von reinem Avarol und Avaron hieraus A process for the simplified preparation of a composition with a high Avarolgehalt having improved activity and the use thereof for treating proliferative disorders or for preparing pure avarol and avarone thereof |
| 03/04/2004 | DE10238045A1 2-Thio-substituierte Imidazolderivate und ihre Verwendung in der Pharmazie 2-thio-substituted imidazole derivatives and their use in the pharmaceutical |
| 03/04/2004 | DE10238002A1 Benzimidazolderivate Benzimidazole derivatives |
| 03/04/2004 | DE10237146A1 Verwendung von Treosulfan und Derivaten davon zur Behandlung der Multiplen Sklerose Use of treosulphan and derivatives thereof for the treatment of multiple sclerosis |
| 03/04/2004 | DE10237056A1 Transdermal therapeutic systems containing buprenorphine, useful in treating pain or urinary incontinence, also containing mu-, kappa- or delta-opioid receptor antagonist to reduce abuse potential |
| 03/04/2004 | CA2733212A1 Arginine silicate inositol complex and use thereof |
| 03/04/2004 | CA2513416A1 Novel antibacterial agents |
| 03/04/2004 | CA2501849A1 2-thio-substituted imidazole derivatives and their use in treating diseases associated with a disorder of the immune system |
| 03/04/2004 | CA2501719A1 Remedy or preventive for kidney disease and method of diagnosing kidney disease |
| 03/04/2004 | CA2499280A1 Inhalation compositions with high drug ratios |
| 03/04/2004 | CA2499278A1 Method of preparing dry powder inhalation compositions |
| 03/04/2004 | CA2497632A1 Novel thiophene derivatives, preparation method thereof and pharmaceutical compositions containing same |
| 03/04/2004 | CA2497582A1 Prophylaxis and treatment of infectious diseases |
| 03/04/2004 | CA2496781A1 Methods for treating patients and identifying therapeutics |
| 03/04/2004 | CA2496686A1 A pharmaceutical preparation containing palladium complex compounds and the uses thereof for treating cancer and autoimmune disease |
| 03/04/2004 | CA2496573A1 Agent for prevention and/or treatment of asthma |
| 03/04/2004 | CA2496485A1 Use of an anti-g-csf or anti-g -csfr antibody or a soluble g- csfr for the treatment or prophylaxis of arthritis |
| 03/04/2004 | CA2496464A1 Agent for prevention and/or treatment of itching |
| 03/04/2004 | CA2496434A1 Biologic skin repair and enhancement |
| 03/04/2004 | CA2496411A1 Dosage forms and related therapies |
| 03/04/2004 | CA2496378A1 Methods of treating involuntary facial spasms and facial wrinkles |
| 03/04/2004 | CA2496376A1 Methods of drug delivery using sulphated chitinous polymers |
| 03/04/2004 | CA2496272A1 Integrin b6 markers for compositions, kits, and methods for identification, assessment, prevention and therapy of cervical cancer |
| 03/04/2004 | CA2496236A1 Preventives/remedies for cancer |
| 03/04/2004 | CA2496234A1 Salt-inducible kinases 2 and use thereof |
| 03/04/2004 | CA2496097A1 Keto cannabinoids with therapeutic indications |
| 03/04/2004 | CA2495962A1 Combination therapy for hyperproliferative diseases |
| 03/04/2004 | CA2495952A1 Preventive therapeutic composition for muscular fatigue, pulled muscle and disease attributed thereto |
| 03/04/2004 | CA2495923A1 Methods for treating fungal infections |
| 03/04/2004 | CA2495913A1 Non-vesicular cationic lipid formulations |
| 03/04/2004 | CA2495903A1 Novel biphenyl and biphenyl-like cannabinoids |
| 03/04/2004 | CA2495893A1 Stable, low free formaldehyde, synergistic antimicrobial compositions of aldehyde donors and dehydroacetic acid |
| 03/04/2004 | CA2495799A1 Combination therapy using a dual ppar alpha/gamma agonist and an angiotensin ii type i receptor antagonist |
| 03/04/2004 | CA2495756A1 Acetophenone potentiators of metabotropic glutamate receptors |
| 03/04/2004 | CA2495689A1 Pharmaceutical compositions |
| 03/04/2004 | CA2495682A1 Method for the prevention and/or treatment of atherosclerosis |
| 03/04/2004 | CA2495603A1 Benzonaphthyridines with pde 3/4 inhibiting activity |
| 03/04/2004 | CA2495597A1 Novel phenanthridines |
| 03/04/2004 | CA2495587A1 Multifunctional cox-2 inhibitors |
| 03/04/2004 | CA2495377A1 Piperidin-2,6-dione pamoate salts and their use for the treatment of stress-related affective disorders |
| 03/04/2004 | CA2495376A1 Modulation of matrix metalloproteinase (mmp) activity with aldosterone blocker(s) |
| 03/04/2004 | CA2495354A1 An agent for inhibiting articular cartilage extracellular matrix degradation |
| 03/04/2004 | CA2494953A1 Beta-lactamase inhibitor prodrug |
| 03/04/2004 | CA2494766A1 Rnai probes targeting cancer-related proteins |
| 03/04/2004 | CA2494764A1 Treatment of melanoma by reduction in clusterin levels |
| 03/04/2004 | CA2494658A1 Use of bupropion for the manufacture of a medicament for treating restless legs syndrome |
| 03/04/2004 | CA2494650A1 Pyridazinone-derivatives as pde4 inhibitors |
| 03/04/2004 | CA2494643A1 Piperidine-n-oxide-derivatives |
| 03/04/2004 | CA2494634A1 Piperidine-pyridazones and phthalazones as pde4 inhibitors |
| 03/04/2004 | CA2494544A1 Method of treating osteoarthritis |
| 03/04/2004 | CA2494210A1 Treatment of lower urinary tract symptoms associated with overactive bladder in men and women |
| 03/04/2004 | CA2494127A1 Pyrimido compounds having antiproliferative activity |
| 03/04/2004 | CA2493747A1 Use of a ppar-alpha agonist to treat weight gain associated with a ppar-gamma agonist treatment |
| 03/04/2004 | CA2493328A1 Use of a papaverine-like vasodilator and pharmaceutical composition |
| 03/03/2004 | EP1394274A2 Methods of testing for bronchial asthma or chronic obstructive pulmonary disease |
| 03/03/2004 | EP1394273A1 Diagnostic method and apparatus |
| 03/03/2004 | EP1394255A2 NANBV diagnostics and vaccines |
| 03/03/2004 | EP1394175A1 Inhibitors of interleukin-1beta converting enzyme |
| 03/03/2004 | EP1394162A1 Intermediates of azole antifungal agents and processes for the preparation thereof |
| 03/03/2004 | EP1394161A1 L−ASCORBIC ACID−2−O−MALEIC ACID−A−TOCOPHEROL DIESTER 1−PROPANOL ADDUCT AND PROCESS FOR PRODUCING THE SAME |
| 03/03/2004 | EP1394159A1 New thiophene derivatives, process for their preparation and pharmaceutical compositions containing them |
| 03/03/2004 | EP1394152A1 2-iminoimidazole derivatives (1) |
| 03/03/2004 | EP1394151A1 Preventives/ remedies for complications of diabetes |
| 03/03/2004 | EP1394150A1 4-Phenylpyridine derivatives and their use as NK-1 receptor antagonists |
| 03/03/2004 | EP1394142A1 Carboxylic acid intermediates of antifungal agents and processes for the preparation thereof |
| 03/03/2004 | EP1393776A1 Use of genes identified to be involved in tumor development for the development of anti-cancer drugs and diagnosis of cancer |
| 03/03/2004 | EP1393749A1 A pharmaceutical preparation in colloidal form useful in the treatment of skin diseases, comprising hyluronic acid |
| 03/03/2004 | EP1393747A1 Preventives/remedies for alzheimer's disease |
| 03/03/2004 | EP1393745A1 Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5'ends |
| 03/03/2004 | EP1393738A1 Drugs for diabetes |